SANUWAVE

SANUWAVE is a medical device company based in Suwanee, Georgia, founded in 2005. The company specializes in innovative wound care solutions using patented Extracorporeal Shock Wave Technology (ESWT) to enhance the body's natural healing processes at the cellular level. Their flagship product, dermaPACE®, is the only FDA-approved device in the U.S. specifically designed for treating diabetic foot ulcers, a condition that can lead to amputations if not addressed. The core service of SANUWAVE is to provide advanced wound care technology that shortens healing times and alleviates pain, offering a more effective alternative to traditional methods. Their products primarily benefit patients with chronic wounds, particularly diabetic foot ulcers, and the healthcare professionals who treat them. By facilitating faster healing, SANUWAVE's technology plays a crucial role in preventing amputations and improving the quality of life for patients and their families. The company is led by CEO Morgan Frank and director Jim Tyler, both of whom bring extensive experience in healthcare and life sciences.

• Employees 46
• Founded 2004
• Annual Revenue $32634000
• Total Funding $36946678